<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04878367</url>
  </required_header>
  <id_info>
    <org_study_id>2021-0956</org_study_id>
    <nct_id>NCT04878367</nct_id>
  </id_info>
  <brief_title>Behavioral Interventions to Reduce Particulate Matter Exposure in Patients With COPD</brief_title>
  <official_title>Behavioral Interventions to Reduce Particulate Matter Exposure in Patients With COPD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Asan Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Asan Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      It is a prospective, multi-institutional clinical study and targets patients diagnosed with&#xD;
      chronic obstructive pulmonary disease. About 120 subjects (35 at Ilsan Paik Hospital, 35 at&#xD;
      Severance Hospital, and 50 at Asan Medical Center in Seoul) will be subject to a random&#xD;
      allocation of 2:1. The arbitration group implements living rules for responding to fine dust,&#xD;
      supports air purifiers, and only general guidance is implemented in the non-property group.&#xD;
      Patients are recruited from Asan Medical Center in Seoul (Songpa-gu, Seoul), Severance&#xD;
      Hospital ( Seodaemun-gu, Seoul), and Ilsan Paik Medical Center (Goyang, Gyeonggi-do) for 12&#xD;
      months. During outpatient visits, lung function tests and airway resistance tests shall be&#xD;
      conducted, and surveys presented in the research plan shall be conducted.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It is a prospective and multi-institutional clinical study targeting patients with chronic&#xD;
      obstructive pulmonary disease in general.&#xD;
&#xD;
      A total of 120 COPD patients will be recruited from three institutions: Asan Medical Center,&#xD;
      Severance Hospital, and Ilsan Paik Hospital. (60/30/30 expected) A panel of COPD patients is&#xD;
      established to conduct prospective studies, and measures to mediate recurrence and&#xD;
      deterioration of adult chronic respiratory diseases due to exposure to fine dust are&#xD;
      presented. Improvement of the lifestyle of the arbitration forces. Detailed research methods&#xD;
      such as air purifier support are presented in the research plan.&#xD;
&#xD;
      In addition, a fine dust measurement researcher visits each household to measure indoor fine&#xD;
      dust concentration. The measurement method of fine dust concentration will be using the&#xD;
      process test method, IoT-based sensors, and direct-to-read measuring devices to measure Air&#xD;
      Korea's air pollution. Detailed visit timing and methods are carried out in the manner&#xD;
      specified in the research plan.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>COPD without intervention group , with intervention group</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pulmonary function test (FEV1/FVC) %</measure>
    <time_frame>12 months</time_frame>
    <description>pulmonary function test (FEV1/FVC) %</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>COPD</condition>
  <arm_group>
    <arm_group_label>COPD_E</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>COPD patients with intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>COPD_C</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>COPD patients without intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Five active practices of living rules for responding to fine dust.</intervention_name>
    <description>Check the fine dust weather forecast&#xD;
Check the operation time and filter of the air purifier&#xD;
Window ventilation&#xD;
Inhalant is used or not&#xD;
Bad fine dust: Refrain from going out</description>
    <arm_group_label>COPD_E</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  40 years of age or older&#xD;
&#xD;
          -  Waste function test results show FEV1/FVC&lt;0.7, FEV1 &lt;80% of forecast&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients under 18 years of age with changes in medication (such as inhalants).&#xD;
&#xD;
          -  Older people over 80 years of age.&#xD;
&#xD;
          -  People with no respiratory symptoms with mMRC 0.&#xD;
&#xD;
          -  Who doesn't understand a simple explanation for fine dust exposure devices.&#xD;
&#xD;
          -  Someone who disagrees with the study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sei won Lee</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul Asan Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sei won Lee</last_name>
    <phone>0230103990</phone>
    <email>iseiwon@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Park</last_name>
    <email>tlscjs3326@naver.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Asan Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>05505</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Youngwon Chang, CRC</last_name>
      <phone>0230104908</phone>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>April 28, 2021</study_first_submitted>
  <study_first_submitted_qc>May 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 7, 2021</study_first_posted>
  <last_update_submitted>October 26, 2021</last_update_submitted>
  <last_update_submitted_qc>October 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Asan Medical Center</investigator_affiliation>
    <investigator_full_name>Sei Won Lee</investigator_full_name>
    <investigator_title>associate professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The resident registration number may be used when requesting data from the National Statistical Office or the Health Review and Assessment Service for future research analysis and data collection.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>Data are available at the time of the analysis of the results after the clinical study.</ipd_time_frame>
    <ipd_access_criteria>Gender, age, smoking power and address are collected anonymously.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

